Skip to Content

23andMe CEO says consumer genetics will be as normal as at-home pregnancy tests

April 9, 2018

23andMe CEO and cofounder Anne Wojcicki says consumers don’t need experts to interpret results from genetic risk tests, and compared the information her company offers to at-home pregnancy tests. She says research by 23andMe and others has shown that the average consumer can understand the results from genetic health profiles—and how those results may, or may not, be indicative of future health risks.

The background: Last month, the FDA gave 23andMe the green light to tell customers whether they have three specific genetic variants of the BRCA1 and BRCA2 genes, which are linked to a higher risk of breast and ovarian cancer. The results will be available through 23andMe’s $199 health and ancestry service.

The backlash: Some critics say it’s irresponsible to provide consumers with this information directly and that people should instead seek out a test ordered by a medical professional who can interpret the results.

23andMe replies: In an editorial published today by Stat, Wojcicki says people should have “more direct access to personalized information so they can take charge of their health” and compares her company’s BRCA test to at-home pregnancy tests, which doctors were initially wary about.

What the future holds: Last year, 23andMe got permission from the FDA to directly tell consumers their risk of developing 10 different diseases, including late-onset Alzheimer’s disease and Parkinson’s, as indicated by their DNA. On top of its new BRCA test, a 23andMe spokesperson told MIT Technology Review, the company plans to launch additional genetic health risk reports for more diseases in the future.

Deep Dive


How scientists want to make you young again

Research labs are pursuing technology to “reprogram” aging bodies back to youth.

Human brain cells transplanted into baby rats’ brains grow and form connections

When lab-grown clumps of human neurons are transplanted into newborn rats, they grow with the animals. The research raises some tricky ethical questions.

Inside the billion-dollar meeting for the mega-rich who want to live forever

Hope, hype, and self-experimentation collided at an exclusive conference for ultra-rich investors who want to extend their lives past 100. I went along for the ride.

The debate over whether aging is a disease rages on

In its latest catalogue of health conditions, the World Health Organization almost equated old age with disease. Then it backed off.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.